Pub MED
Abstracts of the 2019 International Congress of the Parkinson's Disease and Movement Disorders®.NUEVO
[No authors listed]
Mov Disord. 2019 Oct;34 Suppl 2:S1-S930. doi: 10.1002/mds.27795. No abstract available.
Pub MED
Localising movement disorders in childhood.NUEVO
Bamford NS, McVicar K.
Lancet Child Adolesc Health. 2019 Oct 22. pii: S2352-4642(19)30330-X. doi: 10.1016/S2352-4642(19)30330-X. [Epub ahead of print] Review.
Pub MED
Functional movement disorders.NUEVO
Galli S, Béreau M, Magnin E, Moulin T, Aybek S.
Rev Neurol (Paris). 2019 Oct 9. pii: S0035-3787(19)30541-7. doi: 10.1016/j.neurol.2019.08.007. [Epub ahead of print] Review.
Pub MED
A Power Spectral Density-Based Method to Detect Tremor and Tremor Intermittency in Movement Disorders.NUEVO
Luft F, Sharifi S, Mugge W, Schouten AC, Bour LJ, van Rootselaar AF, Veltink PH, Heida T.
Sensors (Basel). 2019 Oct 4;19(19). pii: E4301. doi: 10.3390/s19194301.
Pub MED
Impaired Action Control in Patients With Functional Movement Disorders.NUEVO
van Wouwe NC, Mohanty D, Lingaiah A, Wylie SA, LaFaver K.
J Neuropsychiatry Clin Neurosci. 2019 Oct 7:appineuropsych19030076. doi: 10.1176/appi.neuropsych.19030076. [Epub ahead of print]
Pub MED
Functionally meaningful rating scales in progressive pediatric movement disorders.NUEVO
Perlman S.
Dev Med Child Neurol. 2019 Oct 3. doi: 10.1111/dmcn.14372. [Epub ahead of print] No abstract available.
Pub MED
Deep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence-Based Therapy.NUEVO
Krack P, Volkmann J, Tinkhauser G, Deuschl G.
Mov Disord. 2019 Oct 3. doi: 10.1002/mds.27860. [Epub ahead of print]
Pub MED
Internal Versus External Frame of Reference in Functional Movement Disorders.NUEVO
Vizcarra JA, Hacker S, Lopez-Castellanos R, Ryes L, Laub HN, Marsili L, Dwivedi AK, LaFaver K, Espay AJ.
J Neuropsychiatry Clin Neurosci. 2019 Sep 30:appineuropsych18110290. doi: 10.1176/appi.neuropsych.18110290. [Epub ahead of print]
Pub MED
Determinants of ferritin response to oral iron supplementation in children with sleep movement disorders.NUEVO
DelRosso LM, Yi T, Chan JHM, Wrede JE, Lockhart CT, Ferri R.
Sleep. 2019 Sep 29. pii: zsz234. doi: 10.1093/sleep/zsz234. [Epub ahead of print]
Pub MED
Paroxysmal movement disorders - practical update on diagnosis and management.
De Gusmao CM, Silveira-Moriyama L.
Expert Rev Neurother. 2019 Sep;19(9):807-822. doi: 10.1080/14737175.2019.1648211. Epub 2019 Aug 8.
Pub MED
Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.
Antonazzo M, Botta M, Bengoetxea H, Ruiz-Ortega JÁ, Morera-Herreras T.
Int Rev Neurobiol. 2019;146:229-257. doi: 10.1016/bs.irn.2019.06.012. Epub 2019 Jun 28.
Pub MED
Gabapentin for pain, movement disorders, and irritability in neonates and infants.
Burnsed JC, Heinan K, Letzkus L, Zanelli S.
Dev Med Child Neurol. 2019 Jul 25. doi: 10.1111/dmcn.14324. [Epub ahead of print]
Pub MED
The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders.
Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.
Mov Disord. 2019 Jul;34(7):936-949. doi: 10.1002/mds.27736. Epub 2019 Jun 10. Review.
Pub MED
Cognition and Evolution of Movement Disorders of FOXG1-Related Syndrome.
Wong LC, Wu YT, Hsu CJ, Weng WC, Tsai WC, Lee WT.
Front Neurol. 2019 Jun 28;10:641. doi: 10.3389/fneur.2019.00641. eCollection 2019.
Pub MED
Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders.
Mitchell KT, Volz M, Lee A, San Luciano M, Wang S, Starr PA, Larson P, Galifianakis NB, Ostrem JL.
Stereotact Funct Neurosurg. 2019;97(2):113-119. doi: 10.1159/000500993. Epub 2019 Jul 9.
Pub MED
Antisense therapies for movement disorders.
Scoles DR, Pulst SM.
Mov Disord. 2019 Aug;34(8):1112-1119. doi: 10.1002/mds.27782. Epub 2019 Jul 8. Review.
Pub MED
Recent developments in drug-induced movement disorders: a mixed picture.
Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL.
Lancet Neurol. 2019 Sep;18(9):880-890. doi: 10.1016/S1474-4422(19)30152-8. Epub 2019 Jul 3. Review.
Pub MED
Reliability in Mandibular Movement Evaluation Using Photogrammetry in Patients With Temporomandibular Disorders.
Andrade RM, Guimarães LR, Ribeiro AP, Pasqual Marques A, Crivello O Jr, Gonçalves de Carvalho BK, Amado João SM.
J Manipulative Physiol Ther. 2019 May;42(4):267-275. doi: 10.1016/j.jmpt.2018.11.008. Epub 2019 Jun 29.
Pub MED
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
Peralta C, Biafore F, Depetris TS, Bastianello M.
Curr Neurol Neurosci Rep. 2019 Jun 29;19(8):56. doi: 10.1007/s11910-019-0966-3. Review.
Pub MED
Editorial: Update on movement disorders.
Svenningsson P, Frucht SJ.
Curr Opin Neurol. 2019 Aug;32(4):564-565. doi: 10.1097/WCO.0000000000000709. No abstract available.
Pub MED
A dyadic group-movement therapy with adolescent girls with eating disorders.
Dor-Haim M, Yaroslavsy A, Lev Azolay T, Dascal T, Toledano A, Latzer Y, Stein D.
J Clin Psychol. 2019 Aug;75(8):1429-1443. doi: 10.1002/jclp.22785. Epub 2019 Jun 26.
Pub MED
Gene-targeting approaches for movement disorders: recent advances.
Kaplitt MG.
Curr Opin Neurol. 2019 Aug;32(4):566-570. doi: 10.1097/WCO.0000000000000719.
Pub MED
Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.
Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA.
J Clin Psychopharmacol. 2019 Jul/Aug;39(4):336-343. doi: 10.1097/JCP.0000000000001061.
Pub MED
A comparative study on oral health status in Greek preschool children with neurodevelopmental disorders with movement limitations.
Tzouanaki A, Agouropoulos A, Kavvadia K, Papagiannoulis L.
Spec Care Dentist. 2019 Jul;39(4):421-428. doi: 10.1111/scd.12390. Epub 2019 May 27.
Pub MED
Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.
Bohlega SA, Abou-Al-Shaar H, AlDakheel A, Alajlan H, Bohlega BS, Meyer BF, Monies D, Cupler EJ, Al-Saif AM.
Parkinsonism Relat Disord. 2019 Jul;64:145-149. doi: 10.1016/j.parkreldis.2019.02.039. Epub 2019 Feb 28.
Pub MED
Oro-Pharyngeal Dysphagia in Parkinson's Disease and Related Movement Disorders.
Kwon M, Lee JH.
J Mov Disord. 2019 Sep;12(3):152-160. doi: 10.14802/jmd.19048. Epub 2019 Sep 30.
Pub MED
The Legacy of Charles David Marsden: A Role Model in the Field of Movement Disorders.
Zubko LEBM, Franco MKP, Meira AT, Germiniani FMB, Camargo CHF, Teive HAG.
Eur Neurol. 2019 Sep 19:1-4. doi: 10.1159/000502736. [Epub ahead of print] Review.
Pub MED
The effect of lead, restraint stress or their co-exposure on the movement disorders incidence in male mice.
Hosseini-Sharifabad A, Naghibzadeh S, Hajhashemi V.
Res Pharm Sci. 2019 Aug;14(4):343-350. doi: 10.4103/1735-5362.263558.
Pub MED
Psychosocial correlates of prolonged postpartum depression in mothers of children with movement disorders: cross-sectional study from a paediatric developmental rehabilitation centre in Peshawar.
Habib H, Ali W.
J Pak Med Assoc. 2019 Sep;69(9):1293-1299.
Pub MED
The Impact of Microelectrode Recording on Lead Location in Deep Brain Stimulation for the Treatment of Movement Disorders.
Kochanski RB, Bus S, Brahimaj B, Borghei A, Kraimer KL, Keppetipola KM, Beehler B, Pal G, Metman LV, Sani S.
World Neurosurg. 2019 Aug 23. pii: S1878-8750(19)32248-X. doi: 10.1016/j.wneu.2019.08.092. [Epub ahead of print]
Pub MED
Ocular motor manifestations of movement disorders.
Crotty GF, Chwalisz BK.
Curr Opin Ophthalmol. 2019 Aug 22. doi: 10.1097/ICU.0000000000000605. [Epub ahead of print]
Pub MED
Functional Movement Disorders in Elderly.
Chouksey A, Pandey S.
Tremor Other Hyperkinet Mov (N Y). 2019 Jul 30;9. doi: 10.7916/tohm.v0.691. eCollection 2019.
Pub MED
Rapid eye movement sleep without atonia constitutes increased risk for neurodegenerative disorders.
Dede HÖ, Benbir Senel G, Karadeniz D.
Acta Neurol Scand. 2019 Aug 14. doi: 10.1111/ane.13156. [Epub ahead of print]
Pub MED
Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice.
Ali F, Botha H, Whitwell JL, Josephs KA.
Mov Disord Clin Pract. 2019 Jul 24;6(6):436-439. doi: 10.1002/mdc3.12807. eCollection 2019 Jul.
Pub MED
Spectrum of Movement Disorders in Patients With Neuroinvasive West Nile Virus Infection.
Lenka A, Kamat A, Mittal SO.
Mov Disord Clin Pract. 2019 Jul 16;6(6):426-433. doi: 10.1002/mdc3.12806. eCollection 2019 Jul. Review.
Pub MED
[Deep brain stimulation for movement disorders].
Beudel M, Oterdoom DLM, van Egmond ME, van Laar T, de Koning-Tijssen MAJ, van Dijk JMC.
Ned Tijdschr Geneeskd. 2019 Aug 6;163. pii: D3758. Dutch.
Pub MED
Focused Ultrasound and Other Lesioning Therapies in Movement Disorders.
Walters H, Shah BB.
Curr Neurol Neurosci Rep. 2019 Aug 3;19(9):66. doi: 10.1007/s11910-019-0975-2. Review.
Pub MED
Differential movement of the sciatic nerve and hamstrings during the straight leg raise with ankle dorsiflexion: Implications for diagnosis of neural aspect to hamstring disorders.
Bueno-Gracia E, Pérez-Bellmunt A, Estébanez-de-Miguel E, López-de-Celis C, Shacklock M, Caudevilla-Polo S, González-Rueda V.
Musculoskelet Sci Pract. 2019 Oct;43:91-95. doi: 10.1016/j.msksp.2019.07.011. Epub 2019 Jul 27.
Pub MED
Psychogenic (Functional) Movement Disorders.
Thenganatt MA, Jankovic J.
Continuum (Minneap Minn). 2019 Aug;25(4):1121-1140. doi: 10.1212/CON.0000000000000755.
Pub MED
Movement Disorders in Children.
Pearson TS, Pons R.
Continuum (Minneap Minn). 2019 Aug;25(4):1099-1120. doi: 10.1212/CON.0000000000000756.
Bibliografía científica
